Form 4: Ptc Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Neil Gregory Almstead, CHIEF TECHNICAL OPS OFFICER of Ptc Therapeutics, Inc., sold 2,464 shares of common stock on July 9, 2026 for $90.25 per share.
Summary
- Option exercise/conversion: acquired 2,464 Common Stock at $46.54 ($114,675) on July 9, 2026; holds 62,763 after (Direct).
- Open-market sale: disposed of 2,464 Common Stock at $90.25 ($222,376) on July 9, 2026; holds 60,299 after (Direct).
- Option exercise/conversion: disposed of 2,464 Stock Option (Right to Buy) on July 9, 2026; holds 45,036 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $222,376 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Neil Gregory Almstead — Officer (CHIEF TECHNICAL OPS OFFICER)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-09 | Option exercise/conversion | Common Stock | 2,464 | $47 | $114.7K | 62,763 |
| 2026-07-09 | Open-market sale | Common Stock | 2,464 | $90 | $222.4K | 60,299 |
| 2026-07-09 | Option exercise/conversion | Stock Option (Right to Buy) | 2,464 | — | — | 45,036 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-09 | Option exercise/conversion (2,464 shares) |
| 2026-07-09 | Open-market sale (2,464 shares) |
| 2026-07-09 | Option exercise/conversion (2,464 shares) |
Keywords
insider transaction, Form 4, PTCT, PTC THERAPEUTICS, INC., bearish, Neil Gregory Almstead
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.